BG101067A - Sterol derivatives used for meiosis regulation - Google Patents

Sterol derivatives used for meiosis regulation

Info

Publication number
BG101067A
BG101067A BG101067A BG10106796A BG101067A BG 101067 A BG101067 A BG 101067A BG 101067 A BG101067 A BG 101067A BG 10106796 A BG10106796 A BG 10106796A BG 101067 A BG101067 A BG 101067A
Authority
BG
Bulgaria
Prior art keywords
sterol derivatives
derivatives used
meiosis
regulation
sterols
Prior art date
Application number
BG101067A
Other languages
Bulgarian (bg)
English (en)
Inventor
Anne BYSKOV
Claus Andersen
Lars Nordholm
Henning Thogersen
Ole Wassmann
Ivan Diers
Erling Guddal
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of BG101067A publication Critical patent/BG101067A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BG101067A 1994-06-23 1996-12-18 Sterol derivatives used for meiosis regulation BG101067A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (1)

Publication Number Publication Date
BG101067A true BG101067A (en) 1997-08-29

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101067A BG101067A (en) 1994-06-23 1996-12-18 Sterol derivatives used for meiosis regulation

Country Status (26)

Country Link
US (1) US5716777A (cs)
EP (1) EP0767798B1 (cs)
JP (1) JP3987105B2 (cs)
KR (1) KR100408369B1 (cs)
CN (1) CN1068333C (cs)
AT (1) ATE248852T1 (cs)
AU (1) AU694240B2 (cs)
BG (1) BG101067A (cs)
BR (1) BR9508074A (cs)
CA (1) CA2192941C (cs)
CZ (1) CZ289407B6 (cs)
DE (1) DE69531682T2 (cs)
DK (1) DK0767798T3 (cs)
ES (1) ES2204955T3 (cs)
FI (1) FI117159B (cs)
HU (1) HUT76343A (cs)
IL (1) IL114294A (cs)
IS (1) IS4404A (cs)
MX (1) MX9700174A (cs)
NO (1) NO314534B1 (cs)
PL (1) PL186688B1 (cs)
RU (1) RU2194510C2 (cs)
SI (1) SI9520077A (cs)
SK (1) SK165596A3 (cs)
UA (1) UA51622C2 (cs)
WO (1) WO1996000235A1 (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ279797A3 (cs) * 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
ATE254628T1 (de) * 1995-06-23 2003-12-15 Novo Nordisk As Meiose regulierende verbindungen.
ATE238339T1 (de) 1996-12-20 2003-05-15 Novo Nordisk As Verbindungen zur regulierung der meiose
DE69809905T2 (de) * 1997-05-16 2003-08-28 Akzo Nobel N.V., Arnheim/Arnhem 20-aralkyl-5,alpha,-pregnan derivate
CN1259138A (zh) * 1997-06-04 2000-07-05 阿克佐诺贝尔公司 调节减数分裂的17β－烯丙氧基(硫代)烷基－雄甾烷衍生物
ES2181321T3 (es) 1997-12-18 2003-02-16 Akzo Nobel Nv Derivados 17beta-aril(arilmetil)oxi(tio)alquilandrostano.
ATE256144T1 (de) * 1998-05-13 2003-12-15 Novo Nordisk As Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
AU5408999A (en) * 1998-05-26 1999-12-13 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
JP2003521444A (ja) * 1998-06-19 2003-07-15 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
JP2002532511A (ja) * 1998-12-11 2002-10-02 アクゾ・ノベル・エヌ・ベー 減数分裂調節活性を有する２２ｓ−ヒドロキシコレスタ−８，１４−ジエン誘導体
AU3118200A (en) * 1998-12-14 2000-07-03 Merck & Co., Inc. Hiv integrase inhibitors
KR20010101820A (ko) * 1999-02-10 2001-11-14 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 불포화 콜레스탄 유도체 및 감수분열 조절 약제 제조에있어서 그의 용도
DE60034662T2 (de) * 1999-02-24 2008-01-03 Novo Nordisk A/S Behandlung von unfruchtbarkeit
EP1156822B1 (en) 1999-02-24 2006-02-08 Novo Nordisk A/S Iin vitro method for synchronisation of oocyte maturation
MXPA01008657A (es) * 1999-02-26 2003-06-24 Novo Nordisk As Aumento de la proporcion de implante por esterol que activa la meiosis.
JP2002539134A (ja) * 1999-03-09 2002-11-19 アクゾ・ノベル・エヌ・ベー 減数分裂の阻害のための２２ｒ−ヒドロキシコレスタ−８，１４−ジエン誘導体
CN1222319C (zh) * 1999-09-16 2005-10-12 诺沃挪第克公司 用于体外受精的组合物
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
EP1257279A2 (en) * 2000-02-25 2002-11-20 Schering Aktiengesellschaft Improvement of implantation rate using ff-mas
MXPA02011271A (es) * 2000-05-18 2003-04-25 Schering Ag Fertilizacion de oocitos envejecidos.
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
US9376462B2 (en) 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
US5716777A (en) 1998-02-10
AU694240B2 (en) 1998-07-16
ES2204955T3 (es) 2004-05-01
KR100408369B1 (ko) 2004-04-28
UA51622C2 (uk) 2002-12-16
AU2734395A (en) 1996-01-19
IL114294A (en) 2002-09-12
PL186688B1 (pl) 2004-02-27
PL317830A1 (en) 1997-04-28
RU2194510C2 (ru) 2002-12-20
SI9520077A (sl) 1998-06-30
ATE248852T1 (de) 2003-09-15
NO965516D0 (no) 1996-12-20
NO314534B1 (no) 2003-04-07
WO1996000235A1 (en) 1996-01-04
JP3987105B2 (ja) 2007-10-03
CN1151164A (zh) 1997-06-04
HU9603584D0 (en) 1997-02-28
DE69531682D1 (de) 2003-10-09
FI117159B (fi) 2006-07-14
CA2192941A1 (en) 1996-01-04
FI965144A0 (fi) 1996-12-20
CZ289407B6 (cs) 2002-01-16
EP0767798B1 (en) 2003-09-03
HUT76343A (en) 1997-08-28
FI965144L (fi) 1997-02-20
CZ372596A3 (en) 1997-07-16
EP0767798A1 (en) 1997-04-16
JPH10502060A (ja) 1998-02-24
CN1068333C (zh) 2001-07-11
SK165596A3 (en) 1997-08-06
IL114294A0 (en) 1995-10-31
CA2192941C (en) 2009-04-14
IS4404A (is) 1996-12-23
DE69531682T2 (de) 2004-07-15
MX9700174A (es) 1997-04-30
NO965516L (no) 1997-02-21
DK0767798T3 (da) 2003-12-22
BR9508074A (pt) 1997-08-12

Similar Documents

Publication Publication Date Title
BG101067A (en) Sterol derivatives used for meiosis regulation
IL130249A0 (en) Meiosis regulating compounds
IL124459A0 (en) Antagonists of gonadotropin releasing hormone
GEP20012530B (en) Neuroactive Steroids of the Androstane and Pregnane Series
IL124411A0 (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof
MD1616F2 (en) Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
DE69533991D1 (de) Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
WO1999032097A3 (en) Phytosterol composition for preventing alzheimer's disease
AU5648496A (en) Pyrazolo-(1,5a)pyrimidines, their preparation and their use
MY115211A (en) Novel amino acid derivatives, their preparation and use
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
IL111862A0 (en) N-substituted azabicycloheptane derivatives
AU696230B2 (en) N-substituted 3-azabicyclo (3.2.0)heptane derivatives, the preparation and use thereof
NO20005667L (no) Meioseregulerende forbindelser
MX9803662A (es) Oligopeptidos novedosos, preparacion y uso de estos.
MX9800123A (es) Compuestos que regulan la meiosis.
PL311296A1 (en) Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents
BG102238A (en) New imidazoline-2,4-dions of anticonvulsion effect containing, in the first place, orthosubstituted ar(alk)yl radical, and method for their preparation
BR9713762A (pt) Composto, uso dos mesmos, e, processo para regular a meiose em uma célula germinativa de mamìfero.
MX9706565A (es) Estimulacion de meiosis.
IL143735A0 (en) Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
MY129421A (en) INHIBITORS OF p38